Tablets get major investor attention in DC-to-VC meetings

Tablet-enabled and chronic disease products are getting the most attention from healthIT investors and developers in the "DC-to-VC" initiative, Wil Yu, special assistant for innovation with the Office of the National Coordinator, told FierceMobileHealthcare at last week's World Congress Leadership Summit on mHealth in Boston.

The initiative, a series of more than 15 meetings so far between private companies and HHS regulators, is meant to help new mHealth investors and startups scope out the health IT market, clarify the timelines for key tech-related policies, and navigate the regulatory landscape, Yu said.

In particular, regulators work to help mHealth rookies understand how changing policies, like the new FDA guidance released last week, might affect their development process, Yu said.

The mobile technologies participants have expressed the most excitement about thus far are tablet versions of EHR products and chronic disease management apps, Yu said. The chronic disease apps run the gamut from high-tech remote sensor systems to lower-tech education and reminder services.

To learn more:
- read about HHS' DC-to-VC program
- check out one upcoming DC-to-VC meeting
- get details from a Morgenthaler press release